- Overview:
- This is a study that will test the Eversense continuous glucose monitoring compared to a blood glucose meter in patients that are not on or ever tried a CGM.
- Staus:
- Enrolling
- Clinical Description:
- Evaluate the effectiveness of diabetes management with Eversense CGM system non-adjunctively compared to self-monitoring of blood glucose (SMBG) using a blood glucose (BG) meter in participants with either Type 1 or type 2 diabetes.
- Target Age/Sex:
- Over 18 years, Male and Female
- Benefits:
- Participants will receive at no cost: study product, study materials and study-specific procedures.
- Study Length:
- Aproximately 1 Year
- Link:
- ClinicalTrials.gov
